Aytu Biopharma, Inc (AYTU) Institutional Ownership

Ownership Summary

Aytu Biopharma, Inc (NASDAQ:AYTU) currently has 8 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• On a quarter-over-quarter basis, institutional holdings shifted by 23.53%, with a year-over-year a decrease of 73.33% in the count of filers.
• Of these 8 institutional investors, 3 increased their holdings in Aytu Biopharma, while 2 of them reduced positions, and 3 investors maintained their exposure.
• The aggregate institutional position in Aytu Biopharma now stands at 348.26K shares as of December 2025, after investors increased their holdings (up by 66.35K shares quarter on quarter which is down 1.53Mn shares year over year).
• With 278.58K shares, VANGUARD GROUP INC commands the largest institutional position in Aytu Biopharma as of December 31, 2025, equating to 2.76% of the company.
• Among the most significant buyers of Aytu Biopharma during December 2025 were FNY Investment Advisers, LLC (31.47K), BELLEVUE ASSET MANAGEMENT, LLC (25.01K), Daytona Street Capital LLC (10.00K).
• Leading sellers of Aytu Biopharma stock in December 2025 included UBS Group AG (86), SBI Securities Co., Ltd. (51).
• The top 8 institutional holders of Aytu Biopharma for the quarter ending December 2025 included VANGUARD GROUP INC (278.58K), FNY Investment Advisers, LLC (31.60K), BELLEVUE ASSET MANAGEMENT, LLC (25.01K), Daytona Street Capital LLC (10.00K), UBS Group AG (3.05K), SBI Securities Co., Ltd. (11), VISION FINANCIAL MARKETS LLC (2), TSFG, LLC (1).